Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market by Procedure (Transapical, Transfemoral, Transaortic), Region (North America, Europe, Asia Pacific, South America and Middle East and Africa), Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

 Publisher: Fior Market Research |    Report ID : 71603   |  Published On: December 2018 |   Pages: |   Format:PDF

Global transcatheter aortic valve replacement/implantation (TAVR/TAVI) market is expected to reach USD 6.86 Billion by 2025, at a CAGR of 24.61% from 2018 to 2025. Factors propelling the growth of the market include increasing demand for minimally invasive surgeries, increasing prevalence of severe aortic stenosis and asymptomatic, advancements in the transcatheter aortic valves and increase in adoption rate of TAVI devices, and increasing incidence of cardiovascular diseases. Market Overview: Transcatheter aortic valve implantation (TAVI) helps in supplanting the heart valve with prosthetic valve for treatment of extreme aortic stenosis and mitral regurgitation. Transcatheter aortic valve replacement (TAVR) is executed to treat high-risk patients suffering from aortic stenosis and also involves implantation of transcatheter aortic valves to redevelop the blood circulation ability of the aortic valve. According to press release of American College of Cardiology Foundation in 2017, there are more than 90 million Americans diagnosed by CVD and 8,00,000 deaths informed in the U.S. The TAVI uses a catheter to substitute the heart valve as an alternative to opening the chest and completely removing the affected valve. The TAVI valve is fixed within the contaminated aortic valve. Report Description:
  • The base year for the study has been considered 2017, historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The transcatheter aortic valve replacement/implantation (TAVR/TAVI) market is analysed on the basis of value (USD Million).
  • The study delivers a comprehensive analysis of global transcatheter aortic valve replacement/implantation (TAVR/TAVI) market by procedure and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global transcatheter aortic valve replacement/implantation (TAVR/TAVI) market. This report incorporates the industry analysis which is focused on providing an extensive view of the transcatheter aortic valve replacement/implantation (TAVR/TAVI) market.
  • The study also includes attractiveness analysis of procedure and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the transcatheter aortic valve replacement/implantation (TAVR/TAVI) market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

To learn more about this report, request a free sample copy

Market Dynamics: Drivers:
  • Increasing prevalence of severe aortic stenosis and asymptomatic
  • Advancements in the transcatheter aortic valves and increase in adoption rate of TAVI devices
  • Increasing incidence of cardiovascular diseases
  • Increasing demand for minimally invasive surgeries
Restraints:
  • Stringent government regulations for approval of transcatheter aortic valves
  • High cost associated with TAVI
Opportunities:
  • Use of TAVI systems for new indications
  • Rise in healthcare expenditure in emerging economies
Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Key Findings: All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. Segmentation Analysis: The transcatheter aortic valve replacement/implantation (TAVR/TAVI) market is segmented on the basis of procedure.
  • Procedure segment includes transapical, transfemoral, and transaortic. Transfemoral segment is anticipated to grow with the highest CAGR of 25.31% over the forecast period. The acceptance by majority of doctors due to its positive outcomes of TAVR/TAVI and rise in prevalence of aortic stenosis coupled with an increase in geriatric population are the key factors to drive the demand of transfemoral segment.
Regional Segmentation Analysis: The market is analysed on the basis of five regions namely North America, Europe, Asia Pacific, South America, and Middle East and Africa. North America region valued around USD 1.14 Billion in 2017 where as the Europe region held the second dominant position in the global transcatheter aortic valve replacement/implantation (TAVR/TAVI) market.
  • The high adoption of technologically advanced products, investing in R&D for innovative TAVI, and awareness of minimally invasive procedures are the major factors that led to the growth of transcatheter aortic valve replacement/implantation (TAVR/TAVI) market in North America
  • Europe is the fastest growing region due to the high prevalence of aortic stenosis. The use of specific procedure codes for TAVI, and well- established procedure offering for TAVR/TAVI are creating opportunity for the growth of the market.
Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Competitive Analysis: Key players in the transcatheter aortic valve replacement/implantation (TAVR/TAVI) market are include Abbott Laboratories, Boston Scientific Corporation, JC Medical, Inc., Medtronic plc, NVT AG, Bracco S.p.A., Edwards Lifesciences Corporation, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Transcatheter Technologies GmbH,  SYMETIS, Braile Biomedica, Venus Medtech, Inc., and others.  The Boston Scientific Corporation, Medtronic plc, Meril Life Sciences Pvt. Ltd, and Abbott Laboratories are the top leading players of the market. For instance, in 2018, Boston Scientific acquired Claret Medical, a transcatheter aortic valve replacement system provider company. This acquisition added TAVI products in Boston Scientific portfolio. *All our reports are customizable as per customer requirements Scope
Key Points Information
Evaluate Market Potential Growth Rates (CAGR %) Value (USD Million) {Market Size}
USP of Report Company Share Analysis Competitive & Vendor landscape SWOT Analysis of Each Company Profit Margin Analysis Analysis of More than 30 Countries for Each Segment
Historical Years 2015-2017
Forecast Years 2018-2025
Regional Analysis North America, Europe, Asia Pacific, South America, and Middle East and Africa
Countries Analysis U.S., Canada, Mexico, Germany, France, Sweden, Netherlands, U.K., Italy, Spain, Turkey, Switzerland, Belgium, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Brazil, Saudi Arabia, UAE, Egypt, Nigeria, South Africa
This study forecasts revenue and volume growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global transcatheter aortic valve replacement/implantation (TAVR/TAVI) market on the basis of below mentioned segments: Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market, By Procedure:
  • Transapical
  • Transfemoral
  • Transaortic
Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market, By Regions:
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Sweden
    • Netherlands
    • U.K.
    • Italy
    • Spain
    • Turkey
    • Switzerland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of Middle East and Africa
Table of Contents
  1. Introduction
  2. Research Methodology
  3. Executive Summary
  4. Report Premium Insights
  5. Market Overview
  6. Industry Trend Analysis
  7. Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market by Procedure Analysis
  8. Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market by Region Analysis
  9. Competitive Analysis
  10. Company Profiles
  • Business Overview
  • Products Portfolio
  • Key Insights
  • Recent Developments
  • SWOT Analysis
  • Financial Analysis
  • Market Share Analysis


Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Note: Ask For Table Of Content.

We respect your privacy and do not tolerate spam and will never sell, rent or lease your information away.

We respect your privacy and do not tolerate spam and will never sell, rent or lease your information away.

Our Clients

Contact Us
Call Now